Citigroup
TENX icon

Citigroup’s Tenax Therapeutics TENX Stock Holding History

Citigroup’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
11,623
+11,622
+1,162,200% +$148K ﹤0.01% 4423
2026
Q1 		$16 Hold
1
– – ﹤0.01% 5710
2025
Q4 		$12 Buy
+1
New +$9 ﹤0.01% 5802
2022
Q3 		– Sell
-8
Closed -$4K – 6311
2022
Q2 		$4K Buy
+8
New +$8.01K ﹤0.01% 5716
2016
Q2 		– Hold
0
– – – 7428
2016
Q1 		– Hold
0
– – – 7757
2015
Q4 		– Hold
0
– – – 7859
2015
Q3 		– Hold
0
– -$7K – 7706
2015
Q2 		– Hold
0
– – – 6640
2015
Q1 		– Hold
0
– – – 6613
2014
Q4 		– Hold
0
– – – 6555
2014
Q3 		– Hold
0
– – – 6230
2014
Q2 		– Hold
0
– – – 6133
2014
Q1 		– Hold
0
– – – 6349

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Citigroup's TENX Position: Q2 2026 in Review

Citigroup increased its Tenax Therapeutics (TENX) stake by 1,162,200% in Q2 2026, buying an estimated $148K and bringing the position to 11,623 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #4423.

Citigroup first reported a position in TENX in Q2 2022 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Citigroup held 11,623 shares of Tenax Therapeutics worth $169K as of Q2 2026.
  • Citigroup bought 11,622 Tenax Therapeutics shares in Q2 2026, an estimated $148K.
  • Tenax Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4423 holding.
  • Citigroup first reported a position in Tenax Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.